Notes
Comparative Effectiveness Public Advisory Council
Reference
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review's final report on treatments for atopic dermatitis provides policy recommendations to support appropriate patient access to dupilumab. Internet Document : 8 Jun 2017. Available from: URL: https://icer-review.org/announcements/institute-for-clinical-and-economic-reviews-final-report-on-treatments-for-atopic-dermatitis-provides-policy-recommendations-to-support-appropriate-patient-access-to-dupilumab/
Rights and permissions
About this article
Cite this article
ICER reports dupilumab good value for dermatitis. PharmacoEcon Outcomes News 780, 2 (2017). https://doi.org/10.1007/s40274-017-4054-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4054-0